- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04771455
Testing Intervention Strategies for Addressing Obesity and Binge Eating
March 28, 2023 updated by: Andrea Graham, Northwestern University
The purpose of this study is to conduct a randomized pilot trial of a mobile intervention that targets obesity and binge eating.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
81
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adults age 18 years or older
- Obesity (BMI ≥30)
- Recurrent binge eating (≥12 episodes in the past 3 months)
- Interested in losing weight and reducing binge eating
- Willing to use a mobile application
- Has a smartphone with Internet access and capacity for calls and text messaging
- Has a valid email address
- Has access to a scale
- Not pregnant
- English-speaking
Exclusion Criteria:
- Diagnosis for which the study/intervention is not clinically indicated
- Not currently receiving clinical services for weight management or binge eating
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Condition 1
Behavioral weight loss intervention
|
Participants will receive behavioral weight loss intervention
|
Experimental: Condition 2
Behavioral weight loss intervention and decrease negative affect
|
Participants will receive behavioral weight loss intervention
Participants will receive an intervention component to decrease negative affect
|
Experimental: Condition 3
Behavioral weight loss intervention and decrease unhealthy weight control practices
|
Participants will receive behavioral weight loss intervention
Participants will receive an intervention component to decrease unhealthy weight control practices
|
Experimental: Condition 4
Behavioral weight loss intervention, decrease unhealthy weight control practices, and decrease negative affect
|
Participants will receive behavioral weight loss intervention
Participants will receive an intervention component to decrease negative affect
Participants will receive an intervention component to decrease unhealthy weight control practices
|
Experimental: Condition 5
Behavioral weight loss intervention and decrease overvaluation of weight and shape
|
Participants will receive behavioral weight loss intervention
Participants will receive an intervention component to decrease overvaluation of weight and shape
|
Experimental: Condition 6
Behavioral weight loss intervention, decrease overvaluation of weight and shape, and decrease negative affect
|
Participants will receive behavioral weight loss intervention
Participants will receive an intervention component to decrease negative affect
Participants will receive an intervention component to decrease overvaluation of weight and shape
|
Experimental: Condition 7
Behavioral weight loss intervention, decrease overvaluation of weight and shape, and decrease unhealthy weight control practices
|
Participants will receive behavioral weight loss intervention
Participants will receive an intervention component to decrease unhealthy weight control practices
Participants will receive an intervention component to decrease overvaluation of weight and shape
|
Experimental: Condition 8
Behavioral weight loss intervention, decrease overvaluation of weight and shape, decrease unhealthy weight control practices, and decrease negative affect
|
Participants will receive behavioral weight loss intervention
Participants will receive an intervention component to decrease negative affect
Participants will receive an intervention component to decrease unhealthy weight control practices
Participants will receive an intervention component to decrease overvaluation of weight and shape
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight
Time Frame: Measured at baseline, post-intervention (16-weeks), and 3-month follow-up
|
Changes in weight
|
Measured at baseline, post-intervention (16-weeks), and 3-month follow-up
|
Binge eating episodes
Time Frame: Measured at baseline, post-intervention (16-weeks), and 3-month follow-up
|
Changes in episodes of binge eating
|
Measured at baseline, post-intervention (16-weeks), and 3-month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 16, 2021
Primary Completion (Actual)
November 30, 2022
Study Completion (Actual)
November 30, 2022
Study Registration Dates
First Submitted
February 16, 2021
First Submitted That Met QC Criteria
February 24, 2021
First Posted (Actual)
February 25, 2021
Study Record Updates
Last Update Posted (Actual)
March 30, 2023
Last Update Submitted That Met QC Criteria
March 28, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU00208056
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Behavioral weight loss
-
The Miriam HospitalNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Brown... and other collaboratorsRecruiting
-
University of VermontUniversity of South Carolina; University of TennesseeCompleted
-
University of North Carolina, Chapel HillCompletedOverweight and ObesityUnited States
-
Drexel UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingObesity | Weight LossUnited States
-
Rush University Medical CenterCompleted
-
University of ConnecticutNational Institute of Nursing Research (NINR); University of Southern California and other collaboratorsCompleted
-
Drexel UniversityRecruitingObesity | Weight LossUnited States
-
The Miriam HospitalNational Heart, Lung, and Blood Institute (NHLBI)Unknown
-
Kaiser PermanenteUniversity of Minnesota; Oregon Research InstituteCompleted